Following up on MACPAC’s June 2018 recommendations to improve the operation of the Medicaid Drug Rebate Program, the Commission is examining several additional issues related to outpatient prescription drug coverage and pricing. This presentation focuses on state Medicaid programs’ coverage of new drugs and drugs that have disproportionately high costs and complexity. The presentation looks at proposals for a grace period to allow states to develop coverage criteria for new drugs and new payment and rebate strategies for accelerated approval drugs and high-cost drugs.
An official website of the United States Government -
Official websites use .gov A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
Medicaid and CHIP Payment and Access Commission